Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPP The CNPV program is designed to reduce the drug application review process to 1-2 months WATERTOWN, ...

Disc Medicine recently announced the submission of a New Drug Application for bitopertin for erythropoietic protoporphyria, accompanied by the receipt of the FDA Commissioner’s National Priority ...